Sign in to view content

Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results

Sam E. Mansour, MD, MSc,FACS, FRCS(C)

Video
Published 2018

Related

APEX: A Phase II Randomized Clinical Trial Evaluating the Safety andPreliminary Efficacy of X-82 Administered Orally in the Treatment of Exudative AMD
Michael N. Cohen, MD
Updates from the Field
2020
Preoperative Intravitreal Bevacizumab for TRD Secondary to PDR: A Prospective Randomized Clinical Trial of the PACORES Group
J. Fernando Arevalo, MD, PhD, FACS, FASRS
Annual Meeting Talks
2018
Variability of Retinal Thickness in Diabetic macular edema (DME) Patients Treated with 0.19mg Fluocinolone Acetonide (FAc, ILUVIEN).
Christopher D. Riemann, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more